Unresectable Triple-Negative Breast Carcinoma
11 clinical trials · Condition
◉ Watch Unresectable Triple-Negative Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer (NCT04345913) | National Cancer Institute (NCI) | 2021-03-01 |
| A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors (NCT02498613) | National Cancer Institute (NCI) | 2016-08-31 |
Track Unresectable Triple-Negative Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.